Transform Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$12.3M Buy
14,912
+7,134
+92% +$5.94M 0.75% 43
2024
Q4
$6M Buy
7,778
+2,707
+53% +$2.24M 0.33% 69
2024
Q3
$4.49M Sell
5,071
-191
-4% -$172K 0.3% 73
2024
Q2
$4.76M Sell
5,262
-127
-2% -$102K 0.36% 71
2024
Q1
$4.19M Sell
5,389
-4,050
-43% -$2.88M 0.4% 74
2023
Q4
$5.5M Sell
9,439
-1,533
-14% -$895K 0.54% 64
2023
Q3
$5.89M Sell
10,972
-11,679
-52% -$6.02M 0.62% 54
2023
Q2
$10.6M Sell
22,651
-5,580
-20% -$2.34M 0.95% 32
2023
Q1
$9.69M Buy
28,231
+14,109
+100% +$4.76M 0.91% 33
2022
Q4
$5.17M Buy
+14,122
New +$5.01M 0.58% 59
2018
Q1
Sell
-27,882
Closed -$2.35M 247
2017
Q4
$2.35M Buy
27,882
+1,196
+4% +$102K 0.43% 80
2017
Q3
$2.28M Buy
+26,686
New +$2.19M 0.8% 34
2017
Q2
Sell
-22,264
Closed -$1.87M 99
2017
Q1
$1.87M Buy
22,264
+13,502
+154% +$1.08M 0.7% 35
2016
Q4
$644K Buy
8,762
+697
+9% +$51.9K 0.26% 133
2016
Q3
$647K Sell
8,065
-648
-7% -$51.9K 0.28% 117
2016
Q2
$686K Buy
+8,713
New +$656K 0.29% 113

Other funds holding LLY

Transform Wealth's LLY Position: Q1 2025 in Review

Transform Wealth increased its Eli Lilly (LLY) stake by 92% in Q1 2025, buying an estimated $5.94M and bringing the position to 14,912 shares worth $12.3M. The position accounts for 0.75% of the portfolio, ranked #43.

Transform Wealth first reported a position in LLY in Q2 2016 and has held it in 16 quarters since. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Transform Wealth held 14,912 shares of Eli Lilly worth $12.3M as of Q1 2025.
  • Transform Wealth bought 7,134 Eli Lilly shares in Q1 2025, an estimated $5.94M.
  • Eli Lilly made up 0.75% of Transform Wealth's portfolio in Q1 2025, its #43 holding.
  • Transform Wealth first reported a position in Eli Lilly in Q2 2016 and has held it in 16 quarters since.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Transform Wealth's 13F filing for Q1 2025, filed 15 Apr 2025.